Barclays Issues Pessimistic Forecast for UnitedHealth Group (NYSE:UNH) Stock Price
UnitedHealth Group (NYSE:UNH – Get Free Report) had its price objective reduced by investment analysts at Barclays from $642.00 to $560.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the healthcare conglomerate’s stock. Barclays‘s price target would indicate a potential upside of 31.12% from the company’s previous close. […]
UnitedHealth Group (NYSE:UNH – Get Free Report) had its price objective reduced by investment analysts at Barclays from $642.00 to $560.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the healthcare conglomerate’s stock. Barclays‘s price target would indicate a potential upside of 31.12% from the company’s previous close. […]
